From Clinical Lab Assay to At-Home and Point-of-Care Testing

The world of healthcare is constantly evolving, and recent years have witnessed a significant shift from traditional clinical lab assays to at-home and point-of-care testing. A need for more patient-centric, accessible, and efficient healthcare drives this transformation. Mariely Medina-Rivera, a Research Scientist at iFyber, explains the steps involved in advancing Point of Care (POC) and…
Read More

Choosing between Immunoassays and Molecular Assays

Immunoassays and molecular assays are two distinct diagnostic tests used in healthcare and research, each with unique characteristics and applications. Immunoassays are widely used in clinical diagnostics, disease monitoring, and drug testing. They are employed to measure specific proteins or antigens. On the other hand, molecular assays are vital for genetic testing, pathogen detection, and…
Read More

Osteoinductive & Osteoconductive Biomaterials for Bone Defects: Insights into In Vitro Evaluation

Osteoinductive & osteoconductive biomaterials now play a crucial role in the treatment of traumatic, developmental, and pathological bone defects. Their purpose is to substitute or repair damaged bone. These biomaterials can be permanent or temporary and come in various forms, both natural (e.g., allografts and xenografts) and synthetic (e.g., alloplasts, metals, ceramics, polymers, and composites).…
Read More

Cytotoxicity and Cell Viability: The Big Picture

Determining cytotoxicity is a critical step in assessing the biocompatibility of medical devices, biomaterials, and drug screening. There are a wide variety of methods available to researchers; however, too often cell-based assay results indicating poor cell health without greater context slow down or halt progress on the development of a medical device. Technology is constantly…
Read More